This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Osaka University, Knc Laboratories Co., Ltd., Nard Institute, Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2017)
- Suita, JP (2017)
Company Filing History:
2 out of 1,044 
1 out of 11 
1 out of 12 Years Active: 2017
Title: Shushi Nagamori: Pioneering Innovations in Cancer Imaging
Introduction
Shushi Nagamori, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of medical imaging and cancer treatment. With two patents to his name, Nagamori's work primarily focuses on compounds that enhance the effectiveness of positron emission tomography (PET) imaging and target cancer cells more precisely.
Latest Patents
Nagamori's latest patents include an Aromatic amino acid derivative and a positron emission tomography (PET) probe utilizing this derivative. The compound, adhering to a specific structure defined in the general formula, exhibits a remarkable ability to accumulate in cancer cells selectively, demonstrating affinity for LAT1. This characteristic renders it a highly versatile imaging agent suitable for clinical settings. Additionally, he developed a phenoxyalkylamine compound with a selective inhibitory activity against the LAT-1 transporter, which is highly expressed in tumor cells. These innovations represent a significant leap forward in facilitating early diagnosis and targeted treatment of cancer.
Career Highlights
Throughout his career, Shushi Nagamori has been associated with esteemed institutions like Osaka University and Nard Institute, Ltd. His research has contributed to advancements in PET imaging technology, showcasing his commitment to improving cancer detection and treatment methodologies.
Collaborations
Nagamori has collaborated with distinguished colleagues such as Yoshikatsu Kanai and Hidekazu Nakao, which has not only enriched his research endeavors but also led to the development of impactful inventions in the medical field.
Conclusion
Shushi Nagamori's innovative approach and dedication to his work have positioned him as a prominent figure in the realm of cancer imaging and therapy. His patents reflect a deep understanding of the complexities associated with cancer treatment, and his collaborations exemplify the power of teamwork in advancing healthcare innovations. As research continues, Nagamori's contributions will undoubtedly play a crucial role in shaping the future of medical imaging and cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile